Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer's disease in individuals with subjective cognitive decline
淀粉样蛋白-β 错误折叠作为血浆生物标志物表明主观认知能力下降的个体未来有罹患临床阿尔茨海默病的风险
期刊:Alzheimers Research & Therapy
影响因子:7.9
doi:10.1186/s13195-020-00738-8
Julia Stockmann #, Inge M W Verberk #, Nina Timmesfeld, Robin Denz, Brian Budde, Julia Lange-Leifhelm, Philip Scheltens, Wiesje M van der Flier, Andreas Nabers, Charlotte E Teunissen #, Klaus Gerwert #
